Found 4 articles for: "Mycosis Fungoides"
A Case Series on the Use of Brentuximab Vedotin for the Treatment of Mycosis Fungoides
December 2023 | Volume 22 | Issue 12 | Features | e33 | Copyright © December 2023
Background: Brentuximab vedotin (BV) is an anti-CD30 monoclonal antibody that appears to be more effective against CD30-expressing cutaneous T-cell lymphoma (CTCL) compared to cu...
Read MoreSyringotropic Mycosis Fungoides: A Variant of Folliculotropic or a Distinct Subtype of Adnexotropic Mycosis Fungoides?
December 2022 | Volume 21 | Issue 12 | Case Reports | 1362 | Copyright © December 2022
Mycosis fungoides (MF) is a slowly progressive form of cutaneous T-cell lymphomas (CTCL). MF is classified into 4 subtypes including folliculotropic MF (FMF). Infiltration of both hair follicles and e...
Read MoreMycosis Fungoides: Awareness in Skin of Color
July 2022 | Volume 21 | Issue 7 | Features | 790 | Copyright © July 2022
Over the past decade, what is known about skin of color in the field of dermatology has gained an increasing amount of attention among both clinicians and the general public. Recent efforts have conti...
Read MoreClinical Trial of High-Dose Pegylated-Interferon-Alfa-2b Combined With Phototherapy in Advanced Stage Mycosis Fungoides
March 2021 | Volume 20 | Issue 3 | Editorials | 349 | Copyright © March 2021
The combination of Interferon-α-2b (IFN-α-2b) and phototherapy is highly effective in treating mycosis fungoides (MF) but side effects often lead to discontinuation of therapy.1...
Read More
